Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Cns Pharmaceuticals Inc’s current trading price is -99.91% away from its 52-week high, while its distance from the 52-week low is 11.20%. The stock’s price range during this period has varied between $0.10 and $114.50. The company, active in the Healthcare sector, saw a trading volume of around 4.36 million for the day, considerably lower average daily volume of 15.08 million observed over the last three months.
The stock market performance of Cns Pharmaceuticals Inc has been fairly unsteady. Over the last year, the company’s stock hit its highest at $114.50 on 12/06/23, while the lowest price during the same time frame was $0.10, recorded on 08/16/24.
How Financial Performance Impacts Market Capitalization
Cns Pharmaceuticals Inc (CNSP) has experienced a quarterly decline of -28.82% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 6.10M and boasts a workforce of 5 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.2503, with a change in price of -1.1237. Similarly, Cns Pharmaceuticals Inc recorded 12,167,938 in trading volume during the last 100 days, posting a change of -91.36%.
How CNSP’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for CNSP stands at 0.01. Similarly, the long-term debt-to-equity ratio is also 0.00.
CNSP Stock Stochastic Average
As of today, the raw stochastic average of Cns Pharmaceuticals Inc over the past 50 days is 2.33%. This is a decrease compared to the raw stochastic average of the last 20 days, which was recorded at 14.00%. Additionally, the Stochastic %K and %D values for the company were 22.37% and 27.73%, respectively, over the past 20 days.
CNSP Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. The index has shown a price loss of -99.83% this year. Over the last six months, there has been a stronger performance of -98.35%. The price of CNSP leaped by -5.68% during the last 30 days period. For the last 5-days stocks have slided -7.65%.
